Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis

SIMPLE SUMMARY: Osteosarcoma is the most common solid cancer of the bone. Unfortunately, the expected outcome for patients with this and similar types of cancers has changed little over the last 20 years. One important need is to develop new therapies that overcome the development of drug resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Takashi, Ichikawa, Jiro, Fujimaki, Taro, Taniguchi, Naofumi, Takayama, Yoshihiro, Haro, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690839/
https://www.ncbi.nlm.nih.gov/pubmed/33114161
http://dx.doi.org/10.3390/cancers12113097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690839/
https://www.ncbi.nlm.nih.gov/pubmed/33114161
http://dx.doi.org/10.3390/cancers12113097

Ejemplares similares